Control layer

AegisCore™: programmable safety and activation logic.

The system-level control framework designed to govern when, where, and how the platform acts.

Explore the platform

A context-aware guardian.

AegisCore™ is designed to decide whether a therapeutic action is permitted, based on biological conditions. It is LurexBio’s approach to programmable safety: the design priority that distinguishes a context-aware system from static, always-on delivery.

Temporal control
Contextual activation
Safety gating and authorization
Protective boundaries
Back to the platform
Temporal control

Designed to control how long a signal is presented.

Contextual activation

Activation based on local microenvironment cues.

Multi-factor authorization

Safety gating logic that must be satisfied before the platform acts.

Protective boundary

Designed to keep activity away from healthy tissue.

Precision-first safety

Safety designed in from the start, not added later.

Works with StratIQ™

AegisCore™ authorizes. StratIQ™ optimizes.

What to know about
AegisCore™

Where it fits

AegisCore™ decides whether something should happen. StratIQ™ decides how it should happen best. A gatekeeper can stop an action; a strategist cannot authorize one the gatekeeper has forbidden.

Current status

Claims expansion drafted. Implementation and effectiveness are subject to future validation.

An important note

LurexBio is a preclinical-stage company. Platform descriptions reflect design intentions and scientific hypotheses, not demonstrated results.

Control layer · 3 of 4

How AegisCore™ works

Part of one operating system

  1. 01Sensing
  2. 02Protecting healthy tissue
  3. 03Authorization
  4. 04Timed presentation
  5. 05Contained activity

Step 01

Sensing

A programmable control field is designed to read its surroundings before the platform acts.

Step 02

Protecting healthy tissue

Safety logic is designed to keep healthy cells out of reach.

Step 03

Authorization

When the right conditions are met, the field opens and delivery is allowed to proceed.

Step 04

Timed presentation

Each signal is designed to be presented for a defined period, then fade.

Step 05

Contained activity

Activity is intended to stay within the tumor region, leaving healthy tissue outside the boundary untouched.

Illustrations are conceptual.

Explore the other layers

Designed to install a recognizable immune marker on the tumor cell surface.

Vesicle-mediated membrane fusion designed to deliver the signal to the tumor surface.

The governing decision framework that coordinates every layer as one system.